• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中增殖活性与雌激素受体之间的关系。

Relationship between proliferative activity and estrogen receptors in breast cancer.

作者信息

Silverstrini R, Daidone M G, Di Fronzo G

出版信息

Cancer. 1979 Aug;44(2):665-70. doi: 10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n.

DOI:10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n
PMID:476575
Abstract

The proliferative activity of breast cancer has been analyzed in relation to the hormonal characteristics of the host and of the tumor for 199 patients. The analyses of labeling index frequency distributions of estrogen receptor positive (ER+) and negative (ER-) cancers from premenopausal and postmenopausal patients have allowed us to identify three different kinetic groups. A first group, with a very low proliferative activity, includes ER+ cancers from postmenopausal patients; a second group, with an intermediate proliferative activity, includes ER+ cancers from premenopausal and ER- cancers from postmenopausal patients; and a third group, with a very high proliferative activity, includes ER- cancers from premenopausal patients. Generally, the amount of estrogen receptors in ER+ cancers is inversely correlated with the proliferative activity. Lower levels of ER in premenopausal in comparison to postmenopausal patients were found in low proliferative activity tumors.

摘要

针对199例患者,分析了乳腺癌的增殖活性与宿主及肿瘤激素特征之间的关系。通过对绝经前和绝经后患者雌激素受体阳性(ER+)和阴性(ER-)癌症的标记指数频率分布分析,我们确定了三个不同的动力学组。第一组增殖活性非常低,包括绝经后患者的ER+癌症;第二组增殖活性中等,包括绝经前患者的ER+癌症和绝经后患者的ER-癌症;第三组增殖活性非常高,包括绝经前患者的ER-癌症。一般来说,ER+癌症中雌激素受体的数量与增殖活性呈负相关。在增殖活性低的肿瘤中,发现绝经前患者的ER水平低于绝经后患者。

相似文献

1
Relationship between proliferative activity and estrogen receptors in breast cancer.乳腺癌中增殖活性与雌激素受体之间的关系。
Cancer. 1979 Aug;44(2):665-70. doi: 10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n.
2
Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer.
Breast Cancer Res Treat. 1981;1(3):253-62. doi: 10.1007/BF01806265.
3
Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.人乳腺腺癌中雌二醇和孕酮受体水平与血浆雌激素和孕酮水平的关系。
Cancer Res. 1978 Oct;38(10):3468-73.
4
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.重新评估辅助性乳腺癌试验:通过免疫组化法与提取法评估激素受体状态。
J Natl Cancer Inst. 2006 Nov 1;98(21):1571-81. doi: 10.1093/jnci/djj415.
5
[Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women].[绝经前和绝经后女性乳腺癌中前哨淋巴结阳性风险与雌激素受体的关系]
Rev Esp Med Nucl. 2010 Nov-Dec;29(6):289-92. doi: 10.1016/j.remn.2010.07.002. Epub 2010 Sep 15.
6
Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer.雌激素受体与浸润性乳腺癌病理特征的相关性
Cancer. 1980 Jan 15;45(2):349-53. doi: 10.1002/1097-0142(19800115)45:2<349::aid-cncr2820450226>3.0.co;2-p.
7
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.雌激素受体阳性乳腺癌绝经前后女性之间孕激素受体、FOXA1、GATA3和p53的差异表达
Breast Cancer Res Treat. 2014 Apr;144(2):249-61. doi: 10.1007/s10549-014-2867-0. Epub 2014 Feb 19.
8
Functional estrogen receptors as biochemical marker for the detection of hormone-dependent breast cancer.功能性雌激素受体作为检测激素依赖性乳腺癌的生化标志物。
J Surg Oncol. 1990 Jan;43(1):13-8. doi: 10.1002/jso.2930430105.
9
Estrogen receptor positive operable breast cancer: does menopausal status impact on HER2 and progesterone receptor status?雌激素受体阳性可手术乳腺癌:绝经状态是否影响 HER2 和孕激素受体状态?
Breast. 2011 Dec;20(6):519-24. doi: 10.1016/j.breast.2011.05.009. Epub 2011 Jun 22.
10
Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status.水果、蔬菜和微量营养素与绝经及激素受体状态对乳腺癌的影响
Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1485-94.

引用本文的文献

1
Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4.候选寡核苷酸治疗靶点 miR-330-3p 通过 HDAC4 诱导雌激素受体阳性乳腺癌细胞对他莫昔芬产生耐药性。
Breast J. 2023 Sep 6;2023:2875972. doi: 10.1155/2023/2875972. eCollection 2023.
2
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.白人女性和黑人女性中雌激素受体表达与乳腺癌特异性死亡风险的定量测量。
Breast Cancer Res. 2013;15(5):R90. doi: 10.1186/bcr3486.
3
ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.
雌激素受体(ER)阴性乳腺癌中ER的重新表达及对内分泌治疗的重新致敏
J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):67-78. doi: 10.1007/s10911-009-9113-0. Epub 2009 Mar 5.
4
Biological indices in the assessment of breast cancer.评估乳腺癌的生物学指标。
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.
5
Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.乳腺浸润性癌的原发性化疗:激素受体、p53、c-erbB-2、MiB1、pS2和谷胱甘肽S-转移酶π免疫组化检测的预测价值
Br J Cancer. 1996 Nov;74(9):1458-65. doi: 10.1038/bjc.1996.565.
6
Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.人乳腺癌中的雌激素受体、孕激素受体与细胞增殖
Breast Cancer Res Treat. 1996;37(3):217-28. doi: 10.1007/BF01806503.
7
Cell kinetics and polyamine enzymes in the intestinal mucosa of rats with azoxymethane induced tumours.用氧化偶氮甲烷诱导肿瘤的大鼠肠黏膜中的细胞动力学和多胺酶
Int J Exp Pathol. 1994 Oct;75(5):305-11.
8
Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis.乳腺癌中的胸腺嘧啶核苷标记指数和Ki-67生长分数:与预后的比较及相关性
Breast Cancer Res Treat. 1994;32(2):165-75. doi: 10.1007/BF00665767.
9
Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients.乳腺肿瘤中的雌激素受体:735例患者中与年龄、绝经状态以及流行病学和临床特征的关联
Br J Cancer. 1980 Nov;42(5):635-44. doi: 10.1038/bjc.1980.296.
10
Prognostic implications of mean nuclear diameter in breast cancer.乳腺癌细胞核平均直径的预后意义
Br J Cancer. 1980 Oct;42(4):537-41. doi: 10.1038/bjc.1980.277.